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The t(11;18)(q21;q21) translocation [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] , resulting in a chimeric transcript encoding an API2-MALT1 fusion product, has been clarified as the most frequent chromosome aberration in MALT lymphomas, whose action may lead to an increased inhibition of apoptosis, therefore conferring a survival advantage on tumor cells. It is considered that gastric MALT lymphomas that do not show regression in response to H. pylori eradication usually express the API2-MALT1 chimeric transcript mediated by the t(11;18)(q21;q21) translocation, and that this gene aberration thus serves as a reliable predictive marker for responsiveness to anti-H. pylori treatment [4] .
MALT lymphomas comprise 7.6% of all nonHodgkin's lymphomas and represent one of the most common non-Hodgkin's lymphomas [14] . In a previous report, about 89% of MALT lymphoma cases were H. pylori-positive and 11% were H. pylori-negative, while about 17% of MALT lymphoma cases were API2-MALT1 chimeric transcript-positive and 83% were API2-MALT1 chimeric transcript-negative [15] . Furthermore, 4 cases (7.5%) of H. pylori-positive and API2-MALT1-positive MALT lymphomas and 1 case (1.9%) of an H. pylori-negative and API2-MALT1-negative MALT lymphoma were included in this report [15] .
Histologically, API2-MALT1-positive lymphomas featured dense lymphocytic infiltration, predominantly in the submucosa, and a monotonous proliferation of centrocyte-like cells, infrequent lymphoepithelial lesions, and, often, few reactive components such as plasma cells and eosinophils. These findings were also seen in three patients with API2-MALT1-negative lymphomas who did not respond to treatment. However, marked plasmacytoid differentiation of the tumor cells, simulating an extramedullary plasmacytoma, was also
Introduction
Gastric extranodal marginal-zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) type [1, 2] is strongly related to Helicobacter pylori infection, which has been documented as being involved in up to 90% of patients with low-grade gastric MALT lymphoma. Infection with H. pylori can provide a T-cell-mediated antigenic stimulus that induces the sustained growth of MALT tumors, and the eradication of H. pylori (currently recommended as the treatment observed in two patients with API2-MALT1-negative lymphomas who responded to treatment [16] . In the clinical course of patients with the API2-MALT1 chimeric transcript-positive lymphomas, progression of clinical stage, high-grade transformation, and chromosomal aberrations were not apparent, indicating their high biological stability [17] .
As for patients with H. pylori-negative and API2-MALT1 chimeric transcript-negative lymphomas, information is so scarce that their prognosis remains unknown. We report here a patient with H. pylorinegative and API2-MALT1 translocation-negative lowgrade MALT lymphoma of the stomach, who has been followed conservatively for over 5 years.
Case report
A 71-year-old man with no specific symptoms underwent upper gastrointestinal (GI) tract radiography during a routine medical examination for screening, and an ulcerative lesion with a gathering of thickened folds was detected. Pathological study of the biopsy specimen with H&E and immunohistochemical staining led to a diagnosis of the lesion as low-grade mucosaassociated lymphoid tissue (MALT) lymphoma with out the presence of H. pylori. The absence of H. pylori infection was also confirmed by the 13 C urease breath test (UBT), in addition to repeated immunohistological studies and H. pylori culture studies from biopsy specimens.
Upper GI tract radiography examination demonstrated an ulcerative lesion with a gathering of folds on the posterior wall in the corpus of the stomach (Fig.  1A ,B). Endoscopic ultrasonography (EUS) imaging showed the lesion to have a maximum thickness of about 2 cm, extending over all the layers of the stomach, including the mucosa, submucosa, and muscle layer. Computed tomography (CT) scanning showed the lesion covering almost all the stomach layers, but with no obvious signs of local or distant metastasis. These findings matched those from a screening with magnetic resonance imaging (MRI). Systemic whole-body screening with scintigraphy, using 67 Ga-citrate 74 MBq, demonstrated no distant metastasis. Finally, the patient was diagnosed as having advanced (deeply invading to the gastric mucosa but with no lymph-node metastasis) low-grade MALT lymphoma, with no involvement of H. pylori.
The lymphoma ( Fig. 2A) was comprised of small cells with monoclonal proliferation positive for the lambda (λ) chain of gamma (γ) globulin. Immunoreactive kappa (κ) chain-positive cells were not dominant. Dutcher bodies and lymphoepithelial lesions (LELs) (Fig. 2B) were also observed. The lesion also contained Russell bodies ( Fig. 2C ) with accumulation of denatured γ globulin in the plasma cells. Most of the infiltrating lymphoid cells showed positive immunostaining for the λ chain (Fig. 2D) , CD45 (Fig. 2E) , CD20 (Fig. 2F) , and CD79a, whereas T cells positive for CD3 or CD45R were very few.
All results were carefully explained to the patient, a considerable number of options for medical treatment were explained and proposed, and a curative surgical operation or systemic chemotherapy was strongly recommended. However, the patient refused to undergo any clinical therapy because he had no specific symptoms, pain, or discomfort. The lesion was H. pylori-negative, but triple combination therapy with lansoprazole (LPZ), clarithromycin (CAM), and amoxicillin (AMPC) was tentatively performed for 1 week, with the patient's consent. A regular follow-up A B demonstrated. If a cell contains the t(18q21) translocation, one green, one orange, and one fusion signal pattern will be demonstrated. This case, showed two orange and green fusion signal patterns, reflecting two intact copies of MALT1. The same results were confirmed in all biopsy specimens, and the genetic translocation proved to be absent (Fig. 3A,B) . Endoscopic findings revealed almost no change in the patient's low-grade MALT lymphoma (Fig. 4A-D) , nor did pathologic findings show any change. Followup CT screenings also demonstrated the lesion as showing no change, with no obvious metastasis to the lymph nodes, or distant metastasis.
Discussion
The prognosis of H. pylori-negative and API2-MALT1 translocation-negative low-grade MALT lymphoma is unknown, and a standard treatment has yet to be defined.
The majority of low-grade MALT lymphomas are H. pylori-positive and API2-MALT1 translocationnegative, and are quite sensitive to H. pylori eradication. However, some of them can rapidly develop malignant changes, progressing to the high-grade large-cell type; therefore, very careful attention is required to clarify whether a remission due to H. pylori-eradication is lasting. In contrast, approximately 10% of gastric lowgrade B-cell lymphomas of the mucosa-associated lymphoid tissue (MALT) type are unresponsive to H. pylori eradication treatment, and many of them contain an API2-MALT1 chimeric transcript mediated by the t(11;18)(q21;q21) translocation. Some MALT lymphomas can also be associated with the t(1;14)(p22;q32) translocation [18] or the t(14;18)(q32;q21) translocation [19] . The t(11;18)(q21;q21) translocation fuses the Nterminus of the API2 gene and the C-terminus of the MALT1 gene, generating a functional API2-MALT1 product. The t(1;14)(p22;q32) translocation or the t(14;18)(q32;q21) translocation bring the BCL10 or MALT1 genes, respectively, to the Immunoglobulin Heavy (IGH) locus and deregulate their expression. The oncogenic activity of these chromosomal translocations is linked by the physiological role of BCL10 and MALT1 in antigen receptor-mediated nuclear factor (NF) kappaB activation, and may confer a survival advantage to MALT B-cells, through anti-apoptotic or proliferative transcriptional signals.
The presence of the t(11;18)(q21;q21) translocationinduced API2-MALT1 chimeric transcript can be considered a reliably predictive marker for nonresponsiveness to H. pylori eradication treatment in patients with low-grade gastric MALT lymphoma [3] [4] [5] [6] [7] [8] [9] [10] . Liu et al. [20] documented that they detected the API2-MALT1 transcript in 75% of patients who were nonresponsive to antibiotic therapy, but they did not detect the transcript in responsive patients. They concluded that most H. pylori-associated gastric MALT lymphomas that do not respond to antibiotic therapy are associated with the t(11;18)(q21;q21) translocation [20] . In another report [21] , the t(11;18)(q21;q21) translocation was positive in 43 of 63 gastric MALT lymphomas that were nonresponsive to H. pylori eradication, and, in 48 patients who showed complete regression, 2 who were positive for the t(11;18)(q21;q21) translocation showed a relapse of lymphoma, in the absence of H. pylori reinfection. API2 is expressed in cells that correspond to mature B cells, whereas MALT1 mRNA is detectable in pre-B cells, mature B cells, and plasma cells, so that the fusion of MALT1 to API2 mediated by t(11;18)(q21;q21) is considered to result in an increased inhibition of germinal center B-cell apoptosis and the subsequent development of MALT lymphomas [22] .
Malignant lymphomas can be also seen in patients with hepatitis B virus (HBV) [23] or hepatitis C virus (HCV) [24] infection. HBV is a circular DNA virus with a 3.2-kb partially double-stranded DNA genome, and it can insert several viral genomes into a host cell. HCV is a non-retroviral RNA virus, which can exert its carcinogenic influence through chronic liver damage, consequent cellular regeneration, and stimulation of humoral and cellular immune response. Both acute and chronic HCV infection cause an increase in mutation frequency in the immunoglobulin heavy chain, BCL-6, p53, and beta-catenin genes. HCV can also induce transformation of the ras gene, and the inhibition of apoptosis can be induced by the HCV core protein. HCV is also reported to be well-associated with the formation of Bcell lymphoma. The present patient had no previous history of HBV or HCV infection.
In the present patient, the H. pylori-negative and API2-MALT1 translocation-negative gastric MALT lymphoma has shown no apparent changes in the its morphology over a long-term observation period of more than 5 years. Such an advanced MALT lymphoma suggests a new concept regarding the malignant potential of H. pylori-negative MALT lymphomas. Although curative surgery or systemic chemoradiotherapy should still be considered, the apparent absence of malignant changes in the lymphoma reported here suggests that the prognosis of these lymphomas should be discussed and carefully evaluated, and surgical indications should be determined on a case-by-case basis.
